135 related articles for article (PubMed ID: 9309654)
1. On the inhibition of microbial lipases by tetrahydrolipstatin.
Haalck L; Spener F
Methods Enzymol; 1997; 286():252-63. PubMed ID: 9309654
[No Abstract] [Full Text] [Related]
2. Inhibition of lipases from Chromobacterium viscosum and Rhizopus oryzae by tetrahydrolipstatin.
Potthoff AP; Haalck L; Spener F
Biochim Biophys Acta; 1998 Jan; 1389(2):123-31. PubMed ID: 9461253
[TBL] [Abstract][Full Text] [Related]
3. Covalent inactivation of lipases.
Ransac S; Gargouri Y; Marguet F; Buono G; Beglinger C; Hildebrand P; Lengsfeld H; Hadváry P; Verger R
Methods Enzymol; 1997; 286():190-231. PubMed ID: 9309652
[No Abstract] [Full Text] [Related]
4. A 2-methyleneoxetane analog of orlistat demonstrating inhibition of porcine pancreatic lipase.
Dollinger LM; Howell AR
Bioorg Med Chem Lett; 1998 Apr; 8(8):977-8. PubMed ID: 9871523
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin.
Hadváry P; Lengsfeld H; Wolfer H
Biochem J; 1988 Dec; 256(2):357-61. PubMed ID: 3223916
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of pancreatic and gastric lipases by tetrahydrolipstatin and alkyl-dithio-5-(2-nitrobenzoic acid). A kinetic study with 1,2-didecanoyl-sn-glycerol monolayers.
Ransac S; Gargouri Y; Moreau H; Verger R
Eur J Biochem; 1991 Dec; 202(2):395-400. PubMed ID: 1761041
[TBL] [Abstract][Full Text] [Related]
7. Covalent inhibition of digestive lipases by chiral phosphonates.
Cavalier JF; Buono G; Verger R
Acc Chem Res; 2000 Sep; 33(9):579-89. PubMed ID: 10995195
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of lipoprotein lipase activity by tetrahydrolipstatin.
Lobo LI; Wilton DC
Biochem Soc Trans; 1997 Nov; 25(4):S682. PubMed ID: 9450109
[No Abstract] [Full Text] [Related]
9. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin.
Borgström B
Biochim Biophys Acta; 1988 Oct; 962(3):308-16. PubMed ID: 3167082
[TBL] [Abstract][Full Text] [Related]
10. Anti- and pro-lipase activity of selected medicinal, herbal and aquatic plants, and structure elucidation of an anti-lipase compound.
Ado MA; Abas F; Mohammed AS; Ghazali HM
Molecules; 2013 Nov; 18(12):14651-69. PubMed ID: 24287996
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological investigation of the β-thiolactone and β-lactam analogs of tetrahydrolipstatin.
Aubry S; Aubert G; Cresteil T; Crich D
Org Biomol Chem; 2012 Apr; 10(13):2629-32. PubMed ID: 22354549
[TBL] [Abstract][Full Text] [Related]
12. Nanoemulsified orlistat-embedded multi-unit pellet system (MUPS) with improved dissolution and pancreatic lipase inhibition.
Sangwai M; Sardar S; Vavia P
Pharm Dev Technol; 2014 Feb; 19(1):31-41. PubMed ID: 23259606
[TBL] [Abstract][Full Text] [Related]
13. Structurally diverse vibralactones produced by the fungus Stereum hirsutum.
Liang Y; Li Q; Wei M; Chen C; Sun W; Gu L; Zhu H; Zhang Y
Bioorg Chem; 2020 Jun; 99():103760. PubMed ID: 32251946
[TBL] [Abstract][Full Text] [Related]
14. Tetrahydrolipstatin inhibition, functional analyses, and three-dimensional structure of a lipase essential for mycobacterial viability.
Crellin PK; Vivian JP; Scoble J; Chow FM; West NP; Brammananth R; Proellocks NI; Shahine A; Le Nours J; Wilce MC; Britton WJ; Coppel RL; Rossjohn J; Beddoe T
J Biol Chem; 2010 Sep; 285(39):30050-60. PubMed ID: 20656688
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the inhibitory potential of five squaric acid derivatives against pancreatic lipase.
Bobcheva Z; Zhiryakova D; Guncheva M
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):587-91. PubMed ID: 21438711
[TBL] [Abstract][Full Text] [Related]
16. Large spectral changes accompany the conformational transition of human pancreatic lipase induced by acylation with the inhibitor tetrahydrolipstatin.
Lüthi-Peng Q; Winkler FK
Eur J Biochem; 1992 Apr; 205(1):383-90. PubMed ID: 1555598
[TBL] [Abstract][Full Text] [Related]
17. Nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition.
Dolenc A; Govedarica B; Dreu R; Kocbek P; Srcic S; Kristl J
Int J Pharm; 2010 Aug; 396(1-2):149-55. PubMed ID: 20540997
[TBL] [Abstract][Full Text] [Related]
18. Targeting lipid esterases in mycobacteria grown under different physiological conditions using activity-based profiling with tetrahydrolipstatin (THL).
Ravindran MS; Rao SP; Cheng X; Shukla A; Cazenave-Gassiot A; Yao SQ; Wenk MR
Mol Cell Proteomics; 2014 Feb; 13(2):435-48. PubMed ID: 24345785
[TBL] [Abstract][Full Text] [Related]
19. Surface behaviour of bile salts and tetrahydrolipstatin at air/water and oil/water interfaces.
Tiss A; Ransac S; Lengsfeld H; Hadvàry P; Cagna A; Verger R
Chem Phys Lipids; 2001 May; 111(1):73-85. PubMed ID: 11438285
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba.
Bustanji Y; Al-Masri IM; Mohammad M; Hudaib M; Tawaha K; Tarazi H; Alkhatib HS
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):453-9. PubMed ID: 21028941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
